Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28.7M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
468K
-
Shares change
-
+68K
-
Total reported value, excl. options
-
$973K
-
Value change
-
+$137K
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$2.08
Significant Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q3 2024
19 filings reported holding BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share as of Q3 2024.
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 468K shares
of 28.7M outstanding shares and own 1.63% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (261K shares), GEODE CAPITAL MANAGEMENT, LLC (87.2K shares), CAPTRUST FINANCIAL ADVISORS (27.9K shares), Sheaff Brock Investment Advisors, LLC (20K shares), STATE STREET CORP (17.6K shares), NORTHERN TRUST CORP (13.7K shares), Creative Planning (12.1K shares), XTX Topco Ltd (11.3K shares), IFP Advisors, Inc (10K shares), and MORGAN STANLEY (4.96K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.